0000899243-18-029073.txt : 20181115
0000899243-18-029073.hdr.sgml : 20181115
20181115215304
ACCESSION NUMBER: 0000899243-18-029073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181113
FILED AS OF DATE: 20181115
DATE AS OF CHANGE: 20181115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NOVOSEL THOMAS C
CENTRAL INDEX KEY: 0001229401
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34723
FILM NUMBER: 181188558
MAIL ADDRESS:
STREET 1: AMERICOLD REALTY TRUST
STREET 2: 10 GLENLAKE PARKWAY NE, SUITE 700
CITY: ATLANTA
STATE: 2Q
ZIP: 30328
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMERICOLD REALTY TRUST
CENTRAL INDEX KEY: 0001455863
STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798]
IRS NUMBER: 000000000
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 Glenlake Pkwy., Suite 800 S. Tower
CITY: Atlanta
STATE: GA
ZIP: 30328
BUSINESS PHONE: 678-441-1400
MAIL ADDRESS:
STREET 1: 10 Glenlake Pkwy., Suite 800 S. Tower
CITY: Atlanta
STATE: GA
ZIP: 30328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-13
0
0001455863
AMERICOLD REALTY TRUST
NYSE: COLD
0001229401
NOVOSEL THOMAS C
C/O AMERICOLD REALTY TRUST
10 GLENLAKE PKWY, SOUTH TOWER, SUITE 600
ATLANTA
GA
30328
0
1
0
0
See Remarks
Common Shares of Beneficial Interest
2018-11-13
4
S
0
22726
26.00
D
0
D
Common Shares of Beneficial Interest
2018-11-14
4
M
0
15000
9.81
A
15000
D
Common Shares of Beneficial Interest
2018-11-14
4
S
0
15000
26.5297
D
0
D
Stock Option
9.81
2018-11-14
4
M
0
15000
0.00
D
2023-10-30
Common Shares of Beneficial Interest
15000
0
D
The price reported in Column 4 is a weighted average price. These common shares were sold in multiple transactions at prices ranging from $26.50 to $26.61, inclusive. The reporting person undertakes to provide to Americold Realty Trust, any security holder of Americold Realty Trust, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common shares sold at each separate price within the range set forth above.
On November 14, 2018, Mr. Novosel made an exercise of 15,000 stock options and sold 15,000 common shares of beneficial interest.
Options to acquire common shares vested 20% on October 30, 2014, 2015, 2016, 2017 and 2018.
Chief Accounting Officer and Senior Vice President
/s/ Marc Smernoff, attorney-in-fact
2018-11-15